CoChat

Rates of hypoglycemia in users of sulfonylureas

Van Staa, Tjeerd, Abenhaim, Lucien, Monette, Johanne · 1997 · Journal of Clinical Epidemiology

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Objective To identify the demographic and clinical characteristics of sulfonylurea users. To assess the risk of hypoglycemia in patients treated with sulfonylureas in clinical practice, and to characterize the risk in relation to the different drugs used.Research design and methods A cohort of 33,243 sulfonylurea users chosen from 719 clinical practices in the United Kingdom were identified through the VAMP-Research database. Information on demographic characteristics, medical diagnoses and use of medical services was obtained through the computerized records. For a stratified sample of 500 patients, general practioners completed a structured questionnaire on the duration, treatment, and complications of diabetes mellitus, obesity, alcohol use, and smoking history. Patients with a diagnosis of hypoglycemia, as recorded in the database within a time-window of a sulfonylurea prescription, were identified. Incidence rates per person-year of sulfonylurea therapy were estimated.Results Other than a longer duration of diabetes in users of chlorpropamide, no differences were observed among users of different sulfonylurea agents with respect to diabetic complications, adequacy of diabetic control, obesity, smoking, and excessive alcohol consumption. A diagnosis of hypoglycemia during sulfonylurea therapy was recorded in 605 people over 34,052 person-years of sulfonylurea therapy, which converted into an annual risk of 1.8%. The risk in glibenclamide users was higher than in users of other types of sulfonylureas uses. Duration of therapy, concomitant use of insulin, sulfonylurea-potentiating or antagonizing and concomitant use of beta-blockers were predictive of the risk of developing hypoglycemia.Discussion Drug use patterns showed comparability among users of different sulfonylurea agents. Our findings suggest that the rate of diagnosis of hypoglycemia made by physicians is higher for glibenclamide than for other sulfonylureas. An epidemiological study with objectively diagnosed hypoglycemia should be undertaken to confirm these results.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0895-4356(97)00024-3

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 25 references

Research works printed but not linked: 5

  1. Berger, 1986, Die relative Haeufigkeit der schweren Sulphonylharnstoff-Hypoglykaemie in den letzen 25 Jahren in der Schweiz, Schweiz Med Wochenschr, 116, 145
  2. 1983, Multicentre study: UK prospective study of therapies of maturity onset diabetes, Diabetologica, 24, 404
  3. Hall, 1988, Postmarketing surveillance using a computerized general data base, Pharmaceut Med, 2, 345
  4. Hellman, 1984, Glibenclamide is exceptional among hypoglycaemia agents in accumulating progressively in B-cell rich pancreatic islets, Br J Pharmacol, 82, 689
  5. Seltzer, 1972, Drug-induced hypoglycemia: A report of 57 cases, Diabetes, 21, 955, 10.2337/diab.21.9.955 · DOI · Paper page

Cited by

See all 219

Metadata

Authors
Van Staa, T., Abenhaim, L., & Monette, J.
Affiliations
Jewish General Hospital (CA)
Venue
Journal of Clinical Epidemiology
Publisher
Elsevier BV
Published
1997-06
Volume
50
Issue
6
Pages
735-741
ISSN
0895-4356 (ISSN-L)
OpenAlex
W2164584957
Cited by
211
References
25
Citations by year
2025: 3 · 2024: 7 · 2023: 8 · 2022: 7 · 2021: 4 · 2020: 1 · 2019: 3 · 2018: 8 · 2017: 11 · 2016: 10 · 2015: 14 · 2014: 14 · 2013: 7 · 2012: 14
FWCI
3.56
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Journal of Clinical Epidemiology (publishedVersion)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
Keywords
sulfonylureas, hypoglycemia, glibenclamide, chlorpropamide, diabetes mellitus, hypoglycemia incidence, risk factors, beta-blockers, treatment duration, real-world drug use
MeSH terms
Adult, Aged, Chlorpropamide, Female, Glyburide, Gliclazide, Glipizide, Humans, Hypoglycemia, Hypoglycemic Agents, Male, Middle Aged, Surveys and Questionnaires, Risk, Risk Factors, Sulfonylurea Compounds, Time Factors, Tolbutamide, Incidence, Poisson Distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rates of hypoglycemia in users of sulfonylureas. https://app.cochat.ai/papers/10.1016/s0895-4356(97)00024-3
The paper
Van Staa, T., Abenhaim, L., & Monette, J. (1997). Rates of hypoglycemia in users of sulfonylureas. Journal of Clinical Epidemiology. https://doi.org/10.1016/s0895-4356(97)00024-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.